药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Etorphine
Pivampicillin
The therapeutic efficacy of Pivampicillin can be decreased when used in combination with Sarecycline.
Etorphine
Meticillin
The therapeutic efficacy of Meticillin can be decreased when used in combination with Sarecycline.
Etorphine
Bacampicillin
The therapeutic efficacy of Bacampicillin can be decreased when used in combination with Sarecycline.
Etorphine
Iron sucrose
The serum concentration of Sarecycline can be decreased when it is combined with Iron sucrose.
Etorphine
Mipomersen
Sarecycline may increase the hepatotoxic activities of Mipomersen.
Etorphine
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Sarecycline.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Berotralstat
The serum concentration of Berotralstat can be increased when it is combined with Voxilaprevir.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Filgotinib
The serum concentration of Voxilaprevir can be increased when it is combined with Filgotinib.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Pralsetinib
The serum concentration of Pralsetinib can be increased when it is combined with Voxilaprevir.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Satralizumab
The serum concentration of Voxilaprevir can be decreased when it is combined with Satralizumab.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Abametapir
The serum concentration of Voxilaprevir can be increased when it is combined with Abametapir.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Selpercatinib
The serum concentration of Voxilaprevir can be increased when it is combined with Selpercatinib.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Ozanimod
Voxilaprevir may decrease the excretion rate of Ozanimod which could result in a higher serum level.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Rimegepant
The serum concentration of Rimegepant can be increased when it is combined with Voxilaprevir.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Ubrogepant
The serum concentration of Ubrogepant can be increased when it is combined with Voxilaprevir.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Darolutamide
The serum concentration of Darolutamide can be increased when it is combined with Voxilaprevir.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Cenobamate
The serum concentration of Voxilaprevir can be decreased when it is combined with Cenobamate.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Givosiran
The serum concentration of Voxilaprevir can be increased when it is combined with Givosiran.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Lefamulin
Voxilaprevir may decrease the excretion rate of Lefamulin which could result in a higher serum level.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Acetyldigoxin
Voxilaprevir may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level.